Tatva Chintan Pharma Chem balance sheet

As of Sep 2026

Total assets: ₹1,119cr+23.2% on Sep 2025
Shareholders' equity: ₹815cr+8.0% on Sep 2025
Total debt: ₹170cr+104.8% on Sep 2025
Cash and investments: ₹10.7cr−14.8% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	589	604	526	427	196
	42.8	23.3	21.5	72.9	231
	5.2	5.3	3.1	0.4	0.5
	1.3	1.6	2.8	3.6	0.0
	4.0	4.0	0.0	0.0	0.0
	4.6	5.0	4.3	4.3	2.8
	8.6	9.0	4.3	4.3	2.8
	1.9	9.6	12.6	12.3	12.4
	1.2	1.3	1.1	0.8	0.6
	650	654	571	521	443
	249	196	134	153	162
	0.0	0.0	0.0	10.1	0.0
	178	119	82.5	69.9	84.4
	10.7	5.8	11.4	35.3	27.4
	4.5	3.0	2.7	3.0	17.4
	0.3	0.3	0.2	0.2	0.2
	0.1	0.4	1.1	0.7	3.2
	194	128	98.0	119	133
	23.6	23.9	26.4	23.9	12.9
	469	350	265	298	314
	1,119	1,004	836	819	756
Equity
	23.4	23.4	23.4	23.4	22.2
	791	758	715	714	493
	815	782	739	737	515
	815	782	739	737	515
Liabilities
	4.5	5.0	0.0	0.6	4.2
	4.5	5.0	0.0	0.6	4.2
	3.0	2.6	1.4	1.3	1.1
	8.6	8.8	1.4	2.0	5.4
	166	115	36.4	13.6	166
	85.5	58.2	32.7	45.0	32.2
	9.3	12.7	5.5	8.2	29.7
	260	186	74.5	66.9	228
	0.6	0.6	0.4	0.4	0.3
	2.1	0.3	2.0	0.1	0.2
	32.2	25.8	19.0	12.3	7.7
	296	213	96.0	79.7	236
	304	222	97.4	81.6	242
	1,119	1,004	836	819	756
Assets — additional as-filed lines
	2.3	1.1	7.0	2.1	5.5
Liabilities — additional as-filed lines
	0.2	0.2	0.0	0.0	0.0
	1.1	1.2	0.0	0.0	0.0
Trade payables — MSME split
	19.6	17.5	10.8	—	—
	65.9	40.8	21.9	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

TATVA₹1,565.90

Tatva Chintan Pharma Chem Limited

· Chemicals

₹ CrorePeersVISHNU JUBLCPL KIRIINDUS FOSECOIND CHEMPLASTS DDEVPLSTIK GUJALKALI YASHOMcap ₹3,663 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	195.8	426.5	525.6	604.1	588.8
+ Capital Work-in-Progress	230.7	72.9	21.5	23.3	42.8
+ Other Intangibles	0.5	0.4	3.1	5.3	5.2
+ Intangibles under Development	0.0	3.6	2.8	1.6	1.3
+ Non-current Investments	0.0	0.0	0.0	4.0	4.0
+ Other Non-current Financial Assets	2.8	4.3	4.3	5.0	4.6
Non-current Financial Assets	2.8	4.3	4.3	9.0	8.6
+ Deferred Tax Assets	12.4	12.3	12.6	9.6	1.9
+ Other Non-current Assets	0.6	0.8	1.1	1.3	1.2
Total Non-current Assets	442.7	520.8	571.0	654.2	649.9
Current Assets
+ Inventories	162.5	152.8	134.0	196.1	248.9
+ Current Investments	0.0	10.1	0.0	0.0	0.0
+ Trade Receivables	84.4	69.9	82.5	119.0	178.4
+ Cash & Cash Equivalents	27.4	35.3	11.4	5.8	10.7
+ Other Bank Balances	17.4	3.0	2.7	3.0	4.5
+ Short-term Loans	0.2	0.2	0.2	0.3	0.3
+ Other Current Financial Assets	3.2	0.7	1.1	0.4	0.1
Current Financial Assets	132.6	119.1	98.0	128.4	194.0
+ Other Current Assets	12.9	23.9	26.4	23.9	23.6
Total Current Assets	313.6	297.9	265.2	349.5	468.8
Total Assets	756.3	818.7	836.2	1,003.7	1,118.7
Equity
+ Equity Share Capital	22.2	23.4	23.4	23.4	23.4
+ Other Equity / Reserves	492.6	713.7	715.4	758.4	791.3
Equity — Owners of Parent	514.8	737.1	738.8	781.8	814.7
Total Equity	514.8	737.1	738.8	781.8	814.7
Liabilities
+ Borrowings — Non-current	4.2	0.6	0.0	5.0	4.5
Non-current Financial Liabilities	4.2	0.6	0.0	5.0	4.5
+ Provisions — Non-current	1.1	1.3	1.4	2.6	3.0
Non-current Liabilities	5.4	2.0	1.4	8.8	8.6
+ Borrowings — Current	166.0	13.6	36.4	115.4	165.5
+ Trade Payables	32.2	45.0	32.7	58.2	85.5
+ Other Current Financial Liab	29.7	8.2	5.5	12.7	9.3
Current Financial Liabilities	227.9	66.9	74.5	186.3	260.3
+ Provisions — Current	0.3	0.4	0.4	0.6	0.6
+ Current Tax Liabilities	0.2	0.1	2.0	0.3	2.1
+ Other Current Liabilities	7.7	12.3	19.0	25.8	32.2
Current Liabilities	236.1	79.7	96.0	213.1	295.5
Total Liabilities	241.5	81.6	97.4	221.9	304.1
Total Equity & Liabilities	756.3	818.7	836.2	1,003.7	1,118.7
Assets — additional as-filed lines
+ Current Tax Assets	5.5	2.1	7.0	1.1	2.3
Liabilities — additional as-filed lines
+ Deferred Government Grants — Current	0.0	0.0	0.0	0.2	0.2
+ Deferred Government Grants — Non-current	0.0	0.0	0.0	1.2	1.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	10.8	17.5	19.6
+ Dues to Other Creditors — Current	—	—	21.9	40.8	65.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.